Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Acta Psychiatr Scand

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    November 2017
  1. KRAKAUER K, Nordentoft M, Glenthoj BY, Raghava JM, et al
    White matter maturation during 12 months in individuals at ultra-high-risk for psychosis.
    Acta Psychiatr Scand. 2017 Nov 16. doi: 10.1111/acps.12835.
    PubMed     Text format     Abstract available


  2. MIZUNO Y, Hofer A, Frajo-Apor B, Wartelsteiner F, et al
    Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study.
    Acta Psychiatr Scand. 2017 Nov 15. doi: 10.1111/acps.12838.
    PubMed     Text format     Abstract available


    October 2017
  3. MCCUTCHEON R, Beck K, D'Ambrosio E, Donocik J, et al
    Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.
    Acta Psychiatr Scand. 2017 Oct 26. doi: 10.1111/acps.12825.
    PubMed     Text format     Abstract available


    September 2017
  4. STEGMAYER K, Stettler M, Strik W, Federspiel A, et al
    Resting state perfusion in the language network is linked to formal thought disorder and poor functional outcome in schizophrenia.
    Acta Psychiatr Scand. 2017 Sep 2. doi: 10.1111/acps.12790.
    PubMed     Text format     Abstract available


    August 2017
  5. FAN X, Song X, Zhao M, Jarskog LF, et al
    The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia.
    Acta Psychiatr Scand. 2017 Aug 29. doi: 10.1111/acps.12799.
    PubMed     Text format     Abstract available


  6. EBDRUP BH, Ishoy PL, Fagerlund B, Broberg BV, et al
    'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response.
    Acta Psychiatr Scand. 2017 Aug 28. doi: 10.1111/acps.12795.
    PubMed     Text format    


  7. SPERANDEO R, Maldonato MN, Dell'Orco S
    Comment on 'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia'.
    Acta Psychiatr Scand. 2017 Aug 4. doi: 10.1111/acps.12782.
    PubMed     Text format    


    July 2017
  8. KIM JS, Park CM, Choi JA, Park E, et al
    The association between season of birth, age at onset, and clozapine use in schizophrenia.
    Acta Psychiatr Scand. 2017 Jul 25. doi: 10.1111/acps.12776.
    PubMed     Text format     Abstract available


    May 2017
  9. DEBOST JC, Debost M, Grove J, Mors O, et al
    COMT Val158Met and MTHFR C677T moderate risk of schizophrenia in response to childhood adversity.
    Acta Psychiatr Scand. 2017 May 29. doi: 10.1111/acps.12761.
    PubMed     Text format     Abstract available


  10. WEISS SRB, Blanco C, Wargo EM
    Clarifying the link between cannabis use and risk for psychosis.
    Acta Psychiatr Scand. 2017 May 29. doi: 10.1111/acps.12764.
    PubMed     Text format    


  11. WALTON E, Hibar DP, van Erp TG, Potkin SG, et al
    Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium.
    Acta Psychiatr Scand. 2017;135:439-447.
    PubMed     Text format     Abstract available


  12. VERDOUX H, Pambrun E, Tournier M, Bezin J, et al
    Risk of discontinuation of antipsychotic long-acting injections vs. oral antipsychotics in real-life prescribing practice: a community-based study.
    Acta Psychiatr Scand. 2017;135:429-438.
    PubMed     Text format     Abstract available


    March 2017
  13. NUNEZ C, Paipa N, Senior C, Coromina M, et al
    Global brain asymmetry is increased in schizophrenia and related to avolition.
    Acta Psychiatr Scand. 2017 Mar 23. doi: 10.1111/acps.12723.
    PubMed     Text format     Abstract available


  14. VAN DER STEEN Y, Gimpel-Drees J, Lataster T, Viechtbauer W, et al
    Clinical high risk for psychosis: the association between momentary stress, affective and psychotic symptoms.
    Acta Psychiatr Scand. 2017 Mar 5. doi: 10.1111/acps.12714.
    PubMed     Text format     Abstract available


  15. ISHOY PL, Fagerlund B, Broberg BV, Bak N, et al
    No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia.
    Acta Psychiatr Scand. 2017 Mar 5. doi: 10.1111/acps.12711.
    PubMed     Text format     Abstract available


    February 2017
  16. CARNEY R, Cotter J, Firth J, Bradshaw T, et al
    Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.
    Acta Psychiatr Scand. 2017 Feb 7. doi: 10.1111/acps.12699.
    PubMed     Text format     Abstract available


  17. JAKOBSEN MI, Larsen JR, Svensson CK, Johansen SS, et al
    The significance of sampling time in therapeutic drug monitoring of clozapine.
    Acta Psychiatr Scand. 2017;135:159-169.
    PubMed     Text format     Abstract available


  18. KOHLER O, Petersen L, Mors O, Mortensen PB, et al
    Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study.
    Acta Psychiatr Scand. 2017;135:97-105.
    PubMed     Text format     Abstract available


    December 2016
  19. GLENTHOJ LB, Jepsen JR, Hjorthoj C, Bak N, et al
    Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis.
    Acta Psychiatr Scand. 2016 Dec 18. doi: 10.1111/acps.12682.
    PubMed     Text format     Abstract available


  20. PAILLERE-MARTINOT ML, Galinowski A, Plaze M, Andoh J, et al
    Active and placebo transcranial magnetic stimulation effects on external and internal auditory hallucinations of schizophrenia.
    Acta Psychiatr Scand. 2016 Dec 16. doi: 10.1111/acps.12680.
    PubMed     Text format     Abstract available


  21. JORGENSEN KN, Nesvag R, Nerland S, Morch-Johnsen L, et al
    Brain volume change in first-episode psychosis: an effect of antipsychotic medication independent of BMI change.
    Acta Psychiatr Scand. 2016 Dec 7. doi: 10.1111/acps.12677.
    PubMed     Text format     Abstract available


    November 2016
  22. MUSLINER KL, Munk-Olsen T, Mors O, Ostergaard SD, et al
    Progression from unipolar depression to schizophrenia.
    Acta Psychiatr Scand. 2016 Nov 4. doi: 10.1111/acps.12663.
    PubMed     Text format     Abstract available


    September 2016
  23. ZHENG W, Xiang YT, Xiang YQ, Li XB, et al
    Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
    Acta Psychiatr Scand. 2016 Sep 1. doi: 10.1111/acps.12631.
    PubMed     Text format     Abstract available


    August 2016
  24. WARTELSTEINER F, Mizuno Y, Frajo-Apor B, Kemmler G, et al
    Quality of life in stabilized patients with schizophrenia is mainly associated with resilience and self-esteem.
    Acta Psychiatr Scand. 2016 Aug 6. doi: 10.1111/acps.12628.
    PubMed     Text format     Abstract available


  25. THOMPSON A, Marwaha S, Winsper C, Everard L, et al
    Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort.
    Acta Psychiatr Scand. 2016 Aug 1. doi: 10.1111/acps.12623.
    PubMed     Text format     Abstract available


    July 2016
  26. VIGOD SN, Rochon-Terry G, Fung K, Gruneir A, et al
    Factors associated with postpartum psychiatric admission in a population-based cohort of women with schizophrenia.
    Acta Psychiatr Scand. 2016 Jul 20. doi: 10.1111/acps.12622.
    PubMed     Text format     Abstract available


  27. VANASSE A, Blais L, Courteau J, Cohen AA, et al
    Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.
    Acta Psychiatr Scand. 2016 Jul 12. doi: 10.1111/acps.12621.
    PubMed     Text format     Abstract available


  28. FUSAR-POLI P, Meyer-Lindenberg A
    Forty years of structural imaging in psychosis: promises and truth.
    Acta Psychiatr Scand. 2016 Jul 12. doi: 10.1111/acps.12619.
    PubMed     Text format     Abstract available


    June 2016
  29. NORGAARD H, Sondergaard Pedersen H, Fenger-Gron M, Mors O, et al
    Increased use of primary care during 6 years of prodromal schizophrenia.
    Acta Psychiatr Scand. 2016 Jun 13. doi: 10.1111/acps.12600.
    PubMed     Text format     Abstract available


  30. WOLFGANG FLEISCHHACKER W
    The usefulness of rating scales in patients with schizophrenia.
    Acta Psychiatr Scand. 2016;133:435.
    PubMed     Text format    


    April 2016
  31. KATZ J, d'Albis MA, Boisgontier J, Poupon C, et al
    Similar white matter but opposite grey matter changes in schizophrenia and high-functioning autism.
    Acta Psychiatr Scand. 2016 Apr 22. doi: 10.1111/acps.12579.
    PubMed     Text format     Abstract available


  32. GRAHAM HL, Copello A, Griffith E, Freemantle N, et al
    Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in-patient settings.
    Acta Psychiatr Scand. 2016;133:298-309.
    PubMed     Text format     Abstract available


    March 2016
  33. FIRTH J, Rosenbaum S, Stubbs B, Vancampfort D, et al
    Preferences and motivations for exercise in early psychosis.
    Acta Psychiatr Scand. 2016 Mar 14. doi: 10.1111/acps.12562.
    PubMed     Text format    


    February 2016
  34. SCHIRMBECK F, Swets M, Meijer CJ, Zink M, et al
    Longitudinal association between cognitive performance and obsessive-compulsive symptoms in patients with psychosis and unaffected siblings.
    Acta Psychiatr Scand. 2016 Feb 10. doi: 10.1111/acps.12558.
    PubMed     Text format     Abstract available


    January 2016
  35. JEPPESEN RM, Christensen T, Vestergaard CH
    Changes in the utilization of psychiatric hospital facilities in Denmark by patients diagnosed with schizophrenia from 1970 through 2012: The advent of 'revolving door' patients.
    Acta Psychiatr Scand. 2016 Jan 8. doi: 10.1111/acps.12549.
    PubMed     Text format     Abstract available


  36. HOSETH EZ, Westlye LT, Hope S, Dieset I, et al
    Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls.
    Acta Psychiatr Scand. 2016;133:53-62.
    PubMed     Text format     Abstract available


    December 2015
  37. CARNEY R, Bradshaw T, Yung AR
    Physical health promotion in people with schizophrenia: why we should consider the ultra high-risk state.
    Acta Psychiatr Scand. 2015 Dec 6. doi: 10.1111/acps.12532.
    PubMed     Text format    


    October 2015
  38. FINK M
    Reply: To PMID 23215963.
    Acta Psychiatr Scand. 2015;132:320.
    PubMed     Text format    


  39. WACHTEL L, Commins E, Park M, Rolider N, et al
    Neuroleptic malignant syndrome and delirious mania as malignant catatonia in autism: prompt relief with electroconvulsive therapy.
    Acta Psychiatr Scand. 2015;132:319-20.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: